Search

everythinglearnresearchcommunity

for

Search:↓

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

The document concludes that more research is needed to fully understand the causes of PCOS.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Platelet-rich treatments can help improve wound healing and tissue repair.

Low-dose oral minoxidil is a safe treatment for hair loss, with the main side effect being excessive hair growth. Other side effects like foot swelling, low blood pressure when standing, and heart rate changes are rare.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.